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The ﬁlamentous mold Stachybotrys chartarum
requires water-saturated cellulose to grow, and
when found in an indoor environment, it is an
indicator of significant water intrusion and
damage. Although S. chartarum produces sev-
eral classes of mycotoxins, of greatest concern
are macrocyclic trichothecenes, the most
potent members of a large family of tri-
chothecenes (Miller et al. 2003). These myco-
toxins bind to a single site on eukaryotic
ribosomes and directly inhibit initiation, elon-
gation, or termination of protein synthesis
depending on which trichothecene is bound
(Feinberg and MacLaughlin 1989). There are
two chemotypes of S. chartarum, one produc-
ing several macrocyclic trichothecenes and
another that produces atranones and simple tri-
chothecenes (e.g., trichodermin) but never any
of the macrocyclic trichothecenes (Andersen
et al. 2002). Although animal models of pul-
monary injury demonstrate that macrocyclic
trichothecenes are not the only source of lung
damage, tracheal instillation of spores contain-
ing these mycotoxins results in significantly
more acute injury (Leino et al. 2003; Yike and
Dearborn 2004; Yike et al. 2005).
Concern about S. chartarum in indoor
environments surfaced in the mid-1980s
(Croft et al. 1986). Case reports of exposures
in both residential and the nonindustrial work-
place suggested that chronic indoor exposures
could result in a variety of debilitating respira-
tory and nonrespiratory symptoms, perhaps
including an effect on immune function
(Hodgson et al. 1998; Johanning et al. 1996).
Recent reviews on toxic mold–related health
effects raise both concern and controversy
(Horner 2005; Hossain et al. 2004).
In 1994 we recognized an outbreak of
acute pulmonary hemorrhage in young infants
in Cleveland (Montana et al. 1997). The initial
case–control investigation led by the Centers
for Disease Control and Prevention (CDC)
found an association of this often fatal disorder
with the presence of S. chartarum in the water-
damaged homes of these infants (Etzel et al.
1998). Although subsequent review by the
CDC of the initial field investigation of
10 infant cases and 30 controls has questioned
the strength of the association (Etzel 2003), we
have subsequently cared for an additional
30 cases with the continued observation that
almost 90% of these infants come from homes
with documented S. chartarum (Dearborn et al.
1999, 2002). Others have also seen pulmonary
hemorrhage in infants with toxigenic mold
exposure (Miller et al. 2003), and informal sur-
veillance identiﬁed more than 100 other cases
of acute infant pulmonary hemorrhage diag-
nosed across the United States between 1993
and 1997 (Dearborn et al. 1999). The non-
pulmonary manifestations are similar to those
described in animals exposed to S. chartarum
and are consistent with the immune suppres-
sive, neurotoxic, and hemolytic effects of the tri-
chothecenes and/or accompanying mycotoxins
(Dearborn et al. 2002).
Conclusive evidence regarding the etiology
of the infant pulmonary hemorrhage disorder
and other adverse health effects linked to expo-
sure to this mold awaits the development of
proper biomarkers. At present, there is no reli-
able way to determine human exposure to
S. chartarum (Dillon et al. 1999; Miller et al.
2003). Finding this mold in a patient’s home
or work environment remains circumstantial
evidence without a biological marker docu-
menting the extent and timing of the exposure.
Whether it is infants, older children, or adults, it
is very apparent that the controversy surround-
ing the signiﬁcance of inhalation exposure to
“toxic mold” will continue until quantitative,
dosimeter biomarkers are available and used in
proper epidemiologic studies.
In this report, we present evidence that
satratoxin G (SG), a macrocyclic trichothecene
produced by S. chartarum (Figure 1), forms
covalent adducts with serum albumin. These
adducts may serve as biomarkers of exposure to
S. chartarum similar to the serum albumin
adducts that have been used as exposure
dosimeters for another mycotoxin, afla-
toxin B1, and other xenobiotics and chemicals
(Groopman and Kensler 1999).
Materials and Methods
Experimental design. Figure 2 is a summary of
the in vitro and in vivo experiments and analy-
ses described in this article.
Animal experiments. Animals. Sprague-
Dawley rats were obtained from Charles River
(Wilmington, MA). All animals were housed
in microisolators in the Case Western Reserve
University animal facility and fed the standard
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OBJECTIVE: Despite the growing body of evidence showing adverse health effects from inhalation
exposure to the trichothecene-producing mold Stachybotrys chartarum, controversy remains.
Currently, there are no reliable assays suitable for clinical diagnosis of exposure. We hypothesized
that satratoxin G (SG)–albumin adducts may serve as biomarkers of exposure to this fungus.
DESIGN: We studied the formation of adducts of SG with serum albumin in vitro using Western
blots and mass spectrometry (MS) and searched for similar adducts formed in vivo using human
and animal serum. 
RESULTS: Samples of purified human serum albumin that had been incubated with increasing
concentrations of SG showed concentration-dependent albumin bands in Western blots developed
with anti-SG antibodies. MS analysis found that as many as 10 toxin molecules can be bound
in vitro to one albumin molecule. The sequencing of albumin-adduct tryptic peptides and the
analysis of pronase/aminopeptidase digests demonstrated that lysyl, cysteinyl, and histidyl residues
are involved in the formation of these adducts. Serum samples from three patients with docu-
mented exposure to S. chartarum similarly revealed lysine–, cysteine–, and histidine–SG adducts
after exhaustive digestion, afﬁnity column enrichment, and MS analysis. These adducts were also
found in the sera from rats exposed to the spores of S. chartarum in contrast to control human
subjects and control animals. 
CONCLUSIONS: These data document the occurrence of SG–albumin adducts in both in vitro exper-
iments and in vivo human and animal exposures to S. chartarum. 
RELEVANCE TO CLINICAL PRACTICE: SG–amino acid adducts may serve as reliable dosimeter bio-
markers for detection of exposure to S. chartarum. 
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and water ad libitum. The animal research pro-
tocol has been approved by the Case Western
Reserve University Institutional Animal Care
and Use Committee. The animals were treated
humanely and with regard for the alleviation
of suffering.
Intratracheal instillation of fungal spores.
Seven-day-old rat pups weighing around 10 g
were used for measurements of SG in blood.
Male and female rats weighing 100 g were used
to search for SG–albumin adducts. In both
cases, the animals were anesthetized with isoﬂu-
rane (Baxter, Deerﬁeld, IL). A transverse skin
incision was made, and the trachea was exposed
by blunt dissection. S. chartarum spores (isolate
JS58-17; 4.0 × 105 spores per gram body
weight in SG measuring experiments and
0.5 × 105 spores/gram body weight in albumin
adduct detection experiments) suspended in
50 µL of phosphate-buffered saline (PBS) con-
taining 0.1% Tween-20 were injected directly
into the trachea using a 24 G angiocatheter
attached to a sterile Hamilton syringe. The inci-
sion was closed and treated with New Skin liq-
uid bandage (Medtech Laboratories Inc.,
Jackson, WY) to facilitate healing.
Collection of blood. The animals were
exsanguinated through the right ventricle under
isoflurane anesthesia at indicated times after
spore instillation, and the blood samples were
combined using three animals per time point.
For SG measurements, the blood was immedi-
ately extracted with ethanol (see below),
whereas for albumin adduct detection, the
blood was centrifuged at 1,000 × g for 10 min
and the serum aspirated and stored at –20°C.
Human blood samples. Blood samples were
obtained from three adult patients with docu-
mented exposure to S. chartarum who were
evaluated at the Environmental Health Clinic,
Swetland Center for Environmental Health,
Case Western Reserve University (Cleveland,
OH). The use of human samples was reviewed
and approved by the Institutional Review
Board of the University Hospitals of Cleveland,
and all recruited patients gave informed con-
sent. The sample from patient 1 was taken
approximately 2 months after the completion
of mold remediation in her home. Previous air
sampling in her living room had measured
4,700 S. chartarum spores/m3 (Air-O-Cell; US
Micro-Solutions Inc, Greensburg, PA). Blood
samples from patients 2 and 3 were obtained
while they were still living in their home where
S. chartarum was found in their bedroom car-
peting (1,030 S. chartarum spore equivalents/g;
quantitative polymerase chain reaction, P&K
Microbiology Services, Cherry Hill, NJ).
Control blood samples were received from the
investigators. The blood was centrifuged and
the serum stored at –20°C.
Anti-SG antibodies and SG ELISA.
Polyclonal antibodies against SG were gener-
ously donated by J. Pestka, Michigan State
University (East Lansing, MI). The IgG frac-
tion, obtained by ammonium sulfate precipita-
tion from the sera of rabbits immunized with
the conjugates of bovine serum albumin and
SG (Chung et al. 2003), was puriﬁed by pass-
ing through an affinity column of bovine
serum albumin (Sigma-Aldrich, St. Louis,
MO) conjugated to Amino Link Sepharose
(Pierce, Rockford, IL) to remove antibodies
speciﬁc for bovine albumin epitopes.
SG was measured by ELISA (detection
limit = 0.1 ng/mL) in 1:1 whole blood ethanol
extracts according to the method of Chung
et al. (2003) using anti-SG antibody and
horseradish peroxidase–SG conjugates pro-
vided by J. Pestka.
Formation of albumin–SG adducts in vitro.
Human serum albumin (HSA) isolated from
human blood (Sigma-Aldrich) and/or recombi-
nant HSA (rHSA; GTC Biotherapeutics,
Spencer, MA) was dissolved in PBS at 10 µM
concentration and incubated for 20 hr at
37°C with 0-, 1-, 2-, 5-, 10-, and 20-molar
excess of SG (gift from B. Jarvis, University of
Maryland). The samples were then subjected
to SDS–PAGE followed by Western blots or
dialyzed and analyzed by mass spectrometry
(MS) as described below. A molar ratio of 1:10
of albumin to SG was used for MS studies.
N-α-Acetyl-L-lysine (Sigma-Aldrich) was
dissolved in PBS at 10 µM concentration and
incubated for 20 hr at 37°C with an equimolar
concentration of SG.
Electrophoresis and Western blot analysis.
SDS–PAGE was performed using 12% precast
Criterion gels (Bio-Rad, Hercules, CA). The
proteins were transferred to nitrocellulose, and
Western blots were developed using 1:1,000-
diluted (affinity purified as above) anti-SG
antibody. Alkaline phosphatase anti-rabbit IgG
(Sigma-Aldrich) was used as a secondary anti-
body, and the protein bands were visualized
with an alkaline phosphatase substrate kit
(Bio-Rad).
Preparation of samples for MS analysis
Tryptic digestion of rHSA and human serum.
rHSA was incubated with (1:10 molar ratio of
rHSA to SG) and without SG as described
above and dialyzed against 20 mM ammonium
bicarbonate, pH 7.8. Dialyzed protein was
incubated overnight at 37°C with sequencing-
grade trypsin (Promega, Madison, WI) at
1:100 wt/wt ratio. Samples of human serum
(1–3 mL) were similarly digested with a TCPK
trypsin preparation (Sigma-Aldrich).
Exhaustive digestion of rHSA and serum.
rHSA and rHSA–SG adducts, dialyzed
overnight against 20 mM ammonium bicar-
bonate pH 7.8, were incubated overnight at
37°C with pronase (Calbiochem, EMD
Biosciences, San Diego, CA) at 1:100 wt/wt
ratio and leucine aminopeptidase (Sigma-
Aldrich) at 1:1,000 wt/wt ratio. Human and
Yike et al.
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Figure 1. Structure of SG. Abbreviations: OH,
hydroxyl group; CH3 , methyl group. Figure 2. Experimental design.rat serum (1–3 mL) were similarly digested
except using the leucine aminopeptidase at
1:500 wt/wt. If the digestion to single amino
acids was not complete, carboxypeptidase Y
(Sigma-Aldrich) was added to reconstituted
samples for 4 hr and the analysis was repeated.
Affinity chromatography. Both trypsin
and pronase digested samples were heat inacti-
vated at 60°C for 30 min and centrifuged at
17,000 × g for 20 min before affinity chro-
matography. The afﬁnity column for isolating
peptide and amino acid adducts was prepared
by conjugating anti-SG antibody (see above) to
AminoLink Sepharose (Pierce, Rockford, IL).
Heat-inactivated tryptic and/or pronase digests
from human and rat serum were loaded onto
the column and incubated for 1 hr at room
temperature. The column was extensively
washed with PBS followed by 20 mM ammo-
nium bicarbonate, pH 7.8. Bound adducts
were eluted with 0.02% formic acid and evap-
orated. The samples were reconstituted in
0.1% formic acid and analyzed by MS.
MS instrumentation and analyses. Intact
protein. Intact rHSA was analyzed using
an Applied Biosystems (Framingham, MA)
Q-STAR XL quadrupole time-of-ﬂight (TOF)
mass spectrometer equipped with a nanospray
source or a Bruker (Billerica, MA) Biflex III
TOF mass spectrometer with a matrix-assisted
laser desorption ionization (MALDI) source.
For intact protein analysis by MALDI–
TOF–MS, sinapinic acid was used as the
matrix. One microliter of the saturated matrix
mixture (in a 1:1 acetonitrile: water solution)
was spotted on target with 1 µL of the protein
solution.
Tryptic peptide identiﬁcation. After rHSA
digestion with trypsin, the resulting peptides
were analyzed using MALDI–TOF–MS to
determine their molecular weights. For
MALDI–TOF–MS analysis of the peptides,
the matrix α-cyano-4-hydroxy cinnamic acid
was used. One microliter of the saturated
matrix (in a 1:1 acetonitrile:water solutions)
was spotted on target with 1 µL of the analyte.
Using the m/z values from the mass spectra,
peptide mass fingerprinting (PMF) was per-
formed to determine the identity of the pep-
tides by matching the experimental molecular
weights with the theoretical values calculated
from the protein sequence.
To further conﬁrm the identity of the pep-
tides and locate the modiﬁed amino acids, tan-
dem MS (MS–MS) was performed using the
ThermoElectron LCQ-Deca XP (Thermo-
Electron Corp., Waltham, MA) plus ion trap
mass spectrometer with nanospray source.
Tryptic digests were diluted in 1% acetic acid,
and 2 µL of each sample were pressure injected
onto a self-packed 10 cm × 75 µm inner-
diameter Phenomenex Jupiter (Phenomenex
Inc., Torrance, CA) C18 reversed-phase capil-
lary column. The peptides were eluted from
the column by an acetonitrile and aqueous
0.05 M acetic acid gradient with a ﬂow rate of
approximately 0.25 µL/min at the nanospray
tip. The digest was analyzed by acquiring full
scan mass spectra followed by MS–MS. The
three most abundant ions detected in the full
scan mass spectrum were then selected and
fragmented to yield the MS–MS spectrum of
the peptide. The MS–MS data were analyzed
using the ThermoElectron BioWorks 3.1 pro-
gram (ThermoElectron). All matching spectra
were veriﬁed manually.
The pronase digests were analyzed on the
MALDI–TOF mass spectrometer using the
same matrix and sample preparation detailed
above for the tryptic digest analysis. The limit
of detection for this analysis of human samples
was approximately 10 nmol/mL of serum.
Results
Detection of SG in blood. When 7-day-old
infant rat pups were exposed intratracheally to
high doses (4.0 × 105 spores/gm body weight)
of highly toxic S. chartarum (isolate JS58-17),
SG was detected in ethanol extracts of the whole
blood by SG ELISA only immediately after
instillation (Figure 3). The level of free toxin
decreased below the detection limit within the
next 15 min. No immunoreactive free toxin
could be detected in the sera of exposed animals
between 1 and 72 hr postexposure.
SG adducts in vitro. Detection of
anti-SG–reactive albumin. Samples of puriﬁed
HSA (Sigma-Aldrich) were incubated with
increasing concentrations of SG (PBS, 37°C,
20 hr) and subjected to SDS–PAGE after
reduction and boiling of the samples. Western
blots using anti-SG antibody clearly demon-
strate the HSA band at approximately 67 kDa
(Figure 4) with the intensity of staining increas-
ing with increasing concentrations of SG. This
concentration dependence of the SG staining
that persists through boiling and SDS elec-
trophoresis supports the formation of covalent
SG–albumin adducts. These results were
conﬁrmed using rHSA.
MS analysis of intact protein. When
untreated and SG-incubated rHSA (20 hr,
37°C, PBS, 1:10 protein to toxin ratio) were
analyzed using an electrospray ionization (ESI)
ESI-quadrupole TOF mass spectrometer, a
mass shift was seen in the treated rHSA sam-
ple. This molecular weight increase was indica-
tive of as many as 10 satratoxin molecules
bound to the protein. These results were fur-
ther confirmed using a MALDI–TOF mass
spectrometer (data not shown).
MS analysis of SG–N-acetyl-L-lysine
adduct. Because the ε-amines of lysyl residues
are a likely site of SG nucleophilic attack, we
incubated the toxin with N-α-acetyl-L-lysine
(1:1 molar ratio, 37°C, 20 hr) and analyzed the
resulting SG–lysyl adduct. Figure 5A and B,
Satratoxin G adducts as biomarkers for Stachybotrys
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Figure 3. SG levels in the blood of infant rats
exposed to the spores of S. chartarum.
Figure 4. SDS–PAGE and Western blots of HSA
incubated with different concentrations of SG (3 µg
protein/lane). Western blots were developed with
afﬁnity-puriﬁed anti-SG antibody (Chung et al. 2003).
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Figure 5. (A) Portion of the MALDI–TOF mass spectrum of N-α-acetyl-L-lysine (acLys) incubated with equi-
molar concentration of SG. A peak is detected at m/z 716.8. (B) ESI MS–MS spectrum of the ions at m/z 716.8.shows the spectra from both MALDI–TOF and
ESI MS–MS of the resulting SG–lysyl adduct.
The m/z 716 is consistent with the addition of
528 Da, an apparent loss of oxygen when the
SG bound to the amino acid. When the ions at
m/z 716 were isolated and fragmented, the
MS/MS spectrum contained a peak at m/z 172
representing the N-acetyl lysine as well as a peak
representing a fragment of the toxin at m/z 239,
a convenient marker for this adduct in MS–MS
experiments. This peak at 239 Da is detected
both in the mass spectrum of the toxin mole-
cule alone and as a fragment ion in the MS–MS
spectrum of the toxin molecule.
Detection of adducted tryptic peptides
from rHSA. To locate the sites of SG adduc-
tion to rHSA, both untreated and treated rHSA
were digested with trypsin and analyzed with
MALDI–TOF MS using PMF to identify the
peptides. When analyzing the tryptic peptides
of treated rHSA, several ions were detected that
were consistent with the predicted mass of pep-
tides bound to one SG molecule (Table 1). To
identify the exact position of toxin molecules
on these peptides, the tryptic digests of treated
and control rHSA were analyzed further using
ESI MS–MS (Table 1, Figure 6). Around 60%
coverage was obtained for both samples. The
ions representing tryptic peptides were in the
triply charged state. When the ions at m/z 528
were isolated and fragmented, the resulting
MS–MS spectrum identified the peptide as
K(SG528)YLYEIAR with a calculated mass of
1,582 [(528 × 3) – 2]. Another labeled peptide
was identiﬁed when the ions at m/z 475 were
isolated and fragmented. The fragmentation
pattern in this MS–MS spectrum is consistent
with the peptide LC(SG544)TVATLR with a
calculated mass of 1,423 Da [(475 × 3) – 2].
Last, when the ions at m/z 469 were frag-
mented, the same peptide was identiﬁed, but
with a +528 SG adduct [(469 × 3 )–2 ]=
1,405 Da. As indicated in Table 1, the
sequences of adducted tryptic peptides all con-
tained lysyl, cysteinyl, or histidyl residues (see
below), residues that are likely to be susceptible
to modiﬁcation by the toxin epoxide groups.
Detection of adducted amino acids in pro-
nase digests of rHSA. To further characterize
the rHSA–SG reactivity, exhaustive proteolysis
of reacted rHSA was performed with pronase
and leucine aminopeptidase. The modified
amino acids were puriﬁed using anti-SG anti-
body afﬁnity chromatography and analyzed by
MALDI–TOF–MS. In the MALDI–TOF
mass spectra, several ions were detected corre-
sponding to the amino acids lysine (Lys), histi-
dine (His), and cysteine (Cys), each containing
one SG molecule (Figure 7A). Two different
cysteinyl adducts of +528 and +544 Da were
detected. The amino acid assignments in
Figure 7A were confirmed by ESI MS–MS
(data not shown).
SG–albumin adducts in vivo. Amino acid
SG adducts in pronase digests of human and
rat sera. Subsequently, 2 mL serum samples
from three patients with documented exposure
to S. chartarum and three control subjects were
digested with pronase and leucine aminopepti-
dase, and the adducts were afﬁnity puriﬁed and
analyzed by MALDI–TOF MS. In Figure 7B,
the three top spectra in each panel were
acquired from the samples from exposed
patients, whereas the bottom spectra are from
one of the control subjects. Patients 2 and 3
had a more recent exposure compared to
patient 1. Although cysteinyl adducts were
detected in all three of the exposed patient sam-
ples, lysyl and histidyl adducts were not
detected in patient 1, whose blood sample was
collected 2 months after the termination of
exposure. No amino acid adducts were detected
in the sera from the three control subjects.
Similarly, cysteine–, lysine–, and histidine–SG
adducts were detected after exhaustive proteoly-
sis of the sera of rats exposed intratracheally to
S. chartarum collected 6 hr after the instillation
of fungal spores (Figure 8). No adducts could be
found in parallel samples from control animals.
Adducted tryptic peptides from serum of a
patient exposed to S. chartarum. To demon-
strate the albumin origin of amino acid adducts
detected in samples from human subjects,
serum from patient 3 (most recent exposure, all
three amino acyl adducts detected) was digested
with trypsin and the adducted peptides isolated
Yike et al.
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Table 1. Adducted tryptic peptides from rHSA.
m/z Amino acids Sequencea Adduct
5739.9 277–323 ECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAK 528
4566.2 214–276 VHTECCHGDLLECADDRADLAKYICENQDSISSKLK 544
4565.2 485–519 RPCFSALEVDETYVPKEFNAETFTFHADICTLSEK 528
3487.5 82–106 ETYGEMADCCAKQEPERNECFLQHK 528
2551.5 223–240 FPKAEFAEVSKLVTDLTK 528
2551.5 467–484 TPVSDRVTKCCTESLVNR 544
1914.5 263–274 YICENQDSISSK 528
1582.6 137–144 KYLYEIAR 528
2583.3 145–160 RHPYFYAPELLFFAKR 528
2743.4 175–195 AACLLPKLDELRDEGKASSAK 528
2264.7 219–233 LSQRFPKAEFAEVSK 528
1995.5 337–348 RHPDYSVVLLLR 528
1719.2 277–286 ECCEKPLLEK 528
1404.5 74–81 LCTVATLR 528
1420.5 LCTVATLR 544
1353.6 535–541 HKPKATK 544
1014.2 1–4 DAHK 544
1037.4 535–538 HKPK 528
2599.3 145–160 RHPYFYAPELLFFAKR 544
aPresumed modification sites of peptides analyzed by MALDI–TOF–MS are in bold. Modification sites identified by ESI
MS–MS are underlined.Satratoxin G adducts as biomarkers for Stachybotrys
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with anti-SG immunoafﬁnity chromatography.
Analysis by MALDI–TOF–MS followed with
PMF detected eight peptides with the addi-
tional mass of 528 Da and four with 544 Da
(Table 2). All of the detected tryptic peptides
contained at least one of the three amino acyl
residues, lysyl, cysteinyl, and histidyl, that were
identified as probable modification sites 
in rHSA.
Discussion
In this study we have demonstrated that SG, a
macrocylic trichothecene produced by S. char-
tarum, forms covalent adducts with HSA and
that these adducts can be detected in clinical
samples from patients exposed to this fungus.
Serum albumin adducts have been used as
exposure dosimeters for other toxic agents
including another mycotoxin, aflatoxin B1
(Groopman and Kensler 1999; Guengerich
et al. 2002; Sabbioni et al. 1990). This potent
carcinogen causing hepatocellular carcinoma is
oxidized in the liver by cytochrome P450 to the
epoxide that then reacts with the ε-amine of
lysyl residues either directly or through the
spontaneously formed dialdehyde. The ﬁve pri-
mary macrocyclic trichothecenes produced by
S. chartarum are SG (Figure 1), satratoxin H,
isosatratoxin F, roridin E, and verrucarin J. All
contain an epoxide group that is critical to their
toxicity, and the first and third of this series
contain a second epoxide (Andersen et al. 2002;
Jarvis et al. 1998). These highly reactive groups
are likely to be involved in rapid adduct forma-
tion with proteins, and with inhalation expo-
sure, this reaction would likely occur with
blood proteins in the alveolar capillaries.
The formation of mycotoxins adducts is
consistent with our observation that free SG
could be detected in the blood of rat pups
exposed to the spores of S. chartarum only
immediately after exposure (Figure 3), and
with previous observations of rapid removal
and/or metabolism of trichothecenes (Swanson
and Corley 1989). Reaction with serum albu-
min and other blood proteins is likely responsi-
ble for the rapid disappearance of free toxin
from the blood.
The reaction of SG with tissue and cellular
proteins is also likely. Our ﬁrst experimental
data suggesting the formation of SG–protein
adducts was the detection of immunoreactive
satratoxin in murine tissue sections and cells
obtained by bronchoalveolar lavage. The pres-
ence of satratoxin epitopes in lung sections
that had been extensively rinsed in organic sol-
vents during fixation and staining (Gregory
et al. 2004) indicated that the toxin might be
covalently bound to tissue/cell components.
Western blots showing the staining of albu-
min with anti-SG antibody (Figure 4) were
obtained with reduced and boiled samples,
further suggesting covalent links between the
mycotoxin and protein.
ESI TOF and MALDI–TOF–MS analysis
of the intact adducted protein showed that up
to 10 amino acid residues in the albumin mol-
ecule are modiﬁed after the incubation of the
protein with a 20-fold excess of toxin in vitro.
The extent of albumin modification in vivo
would be dependent upon the level and timing
of exposure and is likely to reﬂect the cumula-
tive nature of chronic exposure. MALDI–
TOF–MS analysis of exhaustive pronase/
aminopeptidase digests of rHSA demonstrated
that in addition to lysyl residues, two other
amino acyl residues, cysteinyl and histidyl, are
involved in adduct formation. All of the rHSA-
derived tryptic peptides with SG adducts had
one of those amino acyl residues within their
sequences, and Cys75 and Lys137 were posi-
tively identiﬁed as modiﬁcation sites using ESI
MS–MS analysis.
Using an affinity column with anti-SG
antibodies to isolate adducts from proteolytic
digests provides a concentrating step that
greatly increases the sensitivity of detection.
Our ability to detect Lys–, Cys–, and His–SG
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Figure 7. MALDI–TOF spectra of amino acid–SG adducts in pronase digests of rHSA (A) and amino
acid–SG adducts in pronase digests of HSA (B) from S. chartarum–exposed and control patients.
Figure 8. MALDI–TOF spectra of cysteine–, lysine–, and histidine–SG adducts from serum of rats exposed
to the spores of S. chartarum.
Table 2. Tryptic peptides from serum albumin of a patient exposed to S. chartarum.
m/z Amino acids Sequencea Adduct
1067.4 435–438 YTKK 528
1109.4 464–468 HPEAK 528
1226.2 29–34 SEVAHR 528
1275.2 215–221 ASSAKQR 528
1418.4 222–229 LKCASLQK 528
1544.9 89–97 SLHTLFGDK 528
1720.3 301–310 ECCEKPLLEK 528
2911.1 76–97 TCVADESAENCDKSLHTLFGDK 528
1053.4 559–562 HKPK 544
1564.0 234–242 AFKAWAVAR 544
2035.2 550–562 QTALVELVKHKPK 544
3910.1 37–65 DLGEENFKALVLIAFAQYLQQCPEEDHVK 544
aAmino acid residues that may be modiﬁed within the peptide are in bold.adducts in pronase/aminopeptidase digests of
serum from patients exposed to S. chartarum in
their homes, in contrast to samples from peo-
ple without mold exposure, demonstrates the
feasibility of a practical biomarker assay.
Detection of modified tryptic peptides with
albumin sequences in the sample of patient’s
serum indicates that those amino acyl adducts
came from serum albumin, although modiﬁca-
tion of other serum proteins is likely. In addi-
tion, the presence of Lys–, Cys–, and His–SG
adducts in the sera from rats exposed intratra-
cheally to the spores of a highly toxic isolate of
S. chartarum further confirms the biomarker
potential of the adducts.
An SG ELISA [the same assay developed
by Chung et al. (2003) used in this study 
to measure SG in blood, as described in
“Materials and Methods”] was used by Brasel
et al. (2004) to detect the toxin in organic sol-
vent extracts of the sera of patients exposed to
molds through indoor air inhalation. Their
removal of proteins before analysis precludes
the detection of albumin–toxin adducts,
although some amino acid and small peptide
toxin adducts may be present in those extracts.
Most of their positive clinical samples con-
tained immunoreactive toxin very close to the
limit of detection. MS analysis detected possi-
ble toxin breakdown products with spectral
properties similar to those of macrocyclic tri-
chothecenes, but the exact nature and origin of
the detected substance  are not known. For this
approach to be quantitatively useful in assess-
ing S. chartarum exposure, the nature and
kinetics of SG metabolism in humans must be
better understood. In addition, our animal
experiments showing rapid loss of detectable
free toxin from the blood after inhalation-type
exposure suggest this analytical approach to be
of limited value.
Other methods to document S. chartarum
exposure include reverse-transcriptase poly-
merase chain reaction (RT-PCR) using species-
specific genomic probes and an ELISA for a
hemolysin produced by this fungus. Although
quantitative PCR is quite sensitive (Haugland
et al. 1999), the collection of proper secretion
samples often requires invasive procedures
(e.g., bronchoscopy) in order to collect secre-
tions likely to contain the fungus, which is also
a time-limited sampling opportunity. In addi-
tion, detection using RT-PCR does not
discriminate between the isolates that produce
macrocyclic trichothecenes and those that do
not. Similarly, the use of the hemolysin as a
biomarker does not distinguish between
macrocyclic trichothecene producers and non-
producers because all of the tested isolates of
S. chartarum seem to produce stachylysin
(Vesper et al. 1999, 2001). The polyclonal
antibodies currently used in the Stachylysin–
ELISA assay (Van Emon et al. 2003) recognize
fungal antigens from other species, such as
Penicillium chrysogenum (Yike I, unpublished
data). A more speciﬁc, monoclonal antibody
may be needed in order to develop a reliable
assay. A monoclonal antibody developed
recently against a spore-speciﬁc antigen from
S. chartarum recognizes a secreted protein
found both in highly toxic isolates and in those
with low toxicity. However, because of its rela-
tively low abundance, this protein may be difﬁ-
cult to detect in human samples (Schmechel
et al. 2006).
Although the exact structures and mecha-
nisms of the SG adduct formation require fur-
ther studies, our ability to detect these adducts
in blood samples of individuals and animals
exposed to S. chartarum in contrast to control
subjects indicates a high potential for this
approach to provide a practical, quantitative
dosimeter. Serum albumin is one of the most
abundant proteins (~ 60 mg/mL) with a half-
life of approximately 20 days. This makes it a
good candidate for a dosimeter of both acute
(days) and fairly recent (weeks to several
months) mold exposure. Our results suggest
that SG–albumin adducts may serve as quanti-
tative biomarkers of inhalation exposure to
S. chartarum and other satratoxin-producing
fungi because they can be readily detected in
small samples of blood.
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